PMINYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31

Picard Medical, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026

$15.45+2.70 (+21.18%)

Close on Oct 19, 2026

Market cap: $28.67M
P/E (TTM): –
Dividend yield: –

Picard Medical, Inc. income statement

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31
Revenue	4.94	4.39
Cost of Revenue	5.14	4.50
Gross Profit	-0.20	-0.11
Research & Development	3.05	3.38
Selling, General & Admin	10	10
Operating Expenses	13	14
Operating Income	-13	-14
Other Non-Operating Income	-14	-7.36
Asset Impairment Charges	0	0
Pretax Income	-27	-21
Income Tax Expense	0.04	-0.02
Net Income	-27	-21
Preferred Dividends	0	2.68
Net Income to Common	-27	-24
EPS (Basic)(per share)	-0.75	-2.99
Shares Outstanding (Basic, Weighted)(shares)	36	7.94
Shares Outstanding (Diluted, Weighted)(shares)	36	7.94
EBITDA	-13	-13

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 18.6%
Operating margin: -248.1%
Net margin: -444.3%
Return on equity, FY2025: 134.3%

Financial strength

Current ratio: 1.02
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 0.5%

Valuation

P/E ratio: –
Price to sales: 4.55
Price to book: 16.71
Dividend yield: –